Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. All Cosmos Bio-Tech Holding's Revenue for the
three
months ended in Dec. 2025 was NT$832 Mil. All Cosmos Bio-Tech Holding's average Accounts Receivable for the
three
months ended in Dec. 2025 was NT$820 Mil.
Hence, All Cosmos Bio-Tech Holding's Receivables Turnover for the
three
months ended in Dec. 2025 was 1.01.
All Cosmos Bio-Tech Holding (TPE:4148) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
All Cosmos Bio-Tech Holding Receivables Turnover Related Terms
All Cosmos Bio-Tech Holding Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
All Cosmos Bio-Tech Holding Receivables Turnover Chart
TPE:4148 vs CTVA, CF, MOS: Receivables Turnover Comparison
For the Agricultural Inputs subindustry, All Cosmos Bio-Tech Holding's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
All Cosmos Bio-Tech Holding Receivables Turnover vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, All Cosmos Bio-Tech Holding's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where All Cosmos Bio-Tech Holding's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
All Cosmos Bio-Tech Holding (TPE:4148) has a Receivables Turnover of 1.01 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on All Cosmos Bio-Tech Holding and its competitors. According to the industry distribution chart, All Cosmos Bio-Tech Holding ranks #157 out of 245 companies in the Agriculture industry, placing it in the top 64.1%.
Is All Cosmos Bio-Tech Holding's Receivables Turnover too high?
All Cosmos Bio-Tech Holding's current Receivables Turnover is 1.01. The Agriculture industry median Receivables Turnover is 5.43. All Cosmos Bio-Tech Holding's value of 1.01 is 81.4% below this industry median. Based on the distribution chart, All Cosmos Bio-Tech Holding ranks #157 out of 245 companies in the Agriculture industry, which is below the industry midpoint. Overall, All Cosmos Bio-Tech Holding has a GF Score™ of 86/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does All Cosmos Bio-Tech Holding's Receivables Turnover compare to CTVA and CF?
According to the Agriculture industry distribution chart, All Cosmos Bio-Tech Holding ranks #157 out of 245 companies for Receivables Turnover. This places All Cosmos Bio-Tech Holding in the lower half of its industry. The industry median Receivables Turnover is 5.43. All Cosmos Bio-Tech Holding's value of 1.01 is 81.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for an Agriculture company?
The median Receivables Turnover among Agriculture companies is 5.43, based on 245 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. All Cosmos Bio-Tech Holding's current Receivables Turnover of 1.01 is 81.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on All Cosmos Bio-Tech Holding and its competitors. For the Agriculture industry, the median Receivables Turnover is 5.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. All Cosmos Bio-Tech Holding's current Receivables Turnover is 1.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is All Cosmos Bio-Tech Holding stock overvalued right now?
Based on GuruFocus' analysis, All Cosmos Bio-Tech Holding (TPE:4148) is currently considered Possible Value Trap. The stock's GF Value™ is NT$48.48, compared to a current price of NT$31.15 — trading 35.7% below its estimated fair value. The current Receivables Turnover is 1.01 and 81.4% below the Agriculture industry median of 5.43. All Cosmos Bio-Tech Holding's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For All Cosmos Bio-Tech Holding (TPE:4148), the current Receivables Turnover is 1.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is All Cosmos Bio-Tech Holding (TPE:4148) Overvalued in 2026?
Based on GuruFocus' analysis, All Cosmos Bio-Tech Holding stock appears to be undervalued.
The current stock price of NT$31.15 is trading 35.7% below its estimated GF Value™ of NT$48.48.
GuruFocus considers All Cosmos Bio-Tech Holding to be Possible Value Trap.
Key valuation signals for TPE:4148:
Receivables Turnover: 1.01
GF Value™: NT$48.48 vs. price of NT$31.15 (35.7% below fair value)
Industry Position: 81.4% below the Agriculture median (#157 of 245)
No single metric tells the full story. See the TPE:4148 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
All Cosmos Bio-Tech Holding Corp is involved in a wide range of industries, mainly divided into 4 focused areas, including agriculture, waste reutilization, health care and pharmaceutical, and research and development of microbials. The group's reportable segments are All Cosmos Industries Sdn. Bhd. (ACI), Sabah Softwoods Hybrid Fertiliser Sdn. Bhd. (SSHF) and others. The majority of its revenue is generated from the ACI segment, which operates as a manufacturer and marketer of Bio-Organic and Bio-Chemical fertilizers. It offers various organic, bio-chemical, bio-control, and chemical fertilizers. Geographically, the group derives maximum revenue from Malaysia and the rest from other markets.
86GF Score
Get the complete analysis for TPE:4148
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4148 has been successfully added to your 
